What is Vyant Bio, Inc.'s current stock price?

Vyant Bio, Inc. (VYNT) currently trades at USD 0.1940. Track real-time price changes and historical performance on AllInvestView.

What sector is Vyant Bio, Inc. in?

Vyant Bio, Inc. operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

Vyant Bio, Inc. VYNT · Stock Open Vyant Bio, Inc. in new tab

0.1940 USD

Add to portfolio

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Vyant Bio, Inc. (VYNT)

Currency: USD

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Vyant Bio, Inc. Analysis (VYNT)

United States Health Care Official Website Stock

Is Vyant Bio, Inc. a good investment? Vyant Bio, Inc. (VYNT) is currently trading at 0.1940 USD.

Investor FAQ

Does Vyant Bio, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Vyant Bio, Inc.?

Vyant Bio, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). Vyant Bio, Inc. has a collaboration agreement to discover drugs for the treatment of Parkinson's Disease. The company is based in Cherry Hill, New Jersey.

Exchange Ticker

NMS (United States) VYNT

Trades

Dividend History paid per year (USD)

No dividend history available.

Stock Splits

Split Date	Split Ratio to 1
Oct. 25, 2019	0.03
Nov. 2, 2022	1:5

Vyant Bio, Inc. VYNT · Stock Open Vyant Bio, Inc. in new tab

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Vyant Bio, Inc. Analysis (VYNT)

Investor FAQ

Company Profile

Fundamentals

Under Construction

Vyant Bio, Inc. VYNT · Stock Open Vyant Bio, Inc. in new tab

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Vyant Bio, Inc. Analysis (VYNT)

Investor FAQ

Company Profile

Explore Premium Features

Fundamentals

Under Construction

Community Discussion

Notifications